Literature DB >> 3030083

MR imaging of pituitary adenoma: CT, clinical, and surgical correlation.

P C Davis, J C Hoffman, T Spencer, G T Tindall, I F Braun.   

Abstract

Twenty-five patients with suspected pituitary adenoma were evaluated prospectively with CT and MR. Nine patients underwent transsphenoidal surgery, and three of these showed a documented decrease in size of mass on bromocriptine therapy. CT was more sensitive than MR for detecting focal lesions (seven vs three) and sellar-floor erosion (12 vs six). MR was superior to CT in identifying infundibular abnormalities (seven vs six), focal abnormalities of the diaphragma sellae (10 vs seven), cavernous sinus invasion (four vs two), and optic chiasm compression (six vs zero). Thus, MR may be the procedure of choice for optimal identification and localization of macroadenoma. For patients with suspected microadenoma, however, this preliminary series indicates that CT remains the radiographic procedure of choice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3030083     DOI: 10.2214/ajr.148.4.797

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

1.  Transnasal Transsphenoidal Approach for Pituitary Tumors: An ENT Perspective.

Authors:  Vaibhav A Chandankhede; S K Singh; Ravi Roy; Sunil Goyal; M S Sridhar; M S Gill
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-02-11

2.  Evaluation of pituitary macroadenomas with multidetector-row CT (MDCT): comparison with MR imaging.

Authors:  Yukio Miki; Mitsunori Kanagaki; Jun A Takahashi; Koichi Ishizu; Masayuki Nakagawa; Akira Yamamoto; Yasutaka Fushimi; Tsutomu Okada; Nobuhiro Mikuni; Ken-ichiro Kikuta; Nobuo Hashimoto; Kaori Togashi
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

Review 3.  Pituitary apoplexy.

Authors:  Wenya Linda Bi; Ian F Dunn; Edward R Laws
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

4.  3D-FT thin sections MRI of prolactin-secreting pituitary microadenomas.

Authors:  N Girard; T Brue; V Chabert-Orsini; C Raybaud; P Jaquet; M Poncet; F Grisoli; S Cahen
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

5.  Pituitary microadenomas. Does Gadolinium enhance their demonstration?

Authors:  P Macpherson; D M Hadley; E Teasdale; G Teasdale
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

6.  Enlargement of the sella turcica in pseudotumor cerebri.

Authors:  Sung-eun E Kyung; James V Botelho; Jonathan C Horton
Journal:  J Neurosurg       Date:  2013-12-06       Impact factor: 5.115

7.  The effect of MR contrast medium dose on pituitary gland enhancement, microlesion enhancement and pituitary gland-to-lesion contrast conspicuity.

Authors:  Walter S Bartynski; John F Boardman; Stephen Z Grahovac
Journal:  Neuroradiology       Date:  2006-05-03       Impact factor: 2.804

8.  Haemorrhagic pituitary tumours.

Authors:  C M Lazaro; W Y Guo; M Sami; T Hindmarsh; K Ericson; A L Hulting; J Wersäll
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

9.  Displacement of the normal pituitary gland by sellar and juxtasellar tumours: surgical-MRI correlation and use in differential diagnosis.

Authors:  M Sumida; T Uozumi; M Yamanaka; K Mukada; K Arita; K Kurisu; H Satoh; F Ikawa
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

10.  The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.

Authors:  T Nakamura; W Schörner; R C Bittner; R Felix
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.